Day: November 9, 2025
The Competition Commission of Pakistan (CCP) has authorised the acquisition of Novartis Pharma (Pakistan) Limited by International Investment Limited (IIL) after completing its phase-I competition assessment under Section 11 of the Competition Act, 2010 and the Competition (Merger Control) Regulations, 2016, Azernews reports, citing Tribune.
